SEC Form 4 · accession 0001437749-16-040133
LIFECORE BIOMEDICAL, INC. \DE\ · LFCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Molly Hemmeter
Officer — Chief Executive Officer
Period of report
Oct 20, 2016
Accepted (ET)
Oct 24, 2016 · 7:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001005286
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Right to Buy Restricted Stock Unit (RSU)F2,F3 | — | Oct 20, 2016 | M | 23,703 | A | Oct 20, 2018 | — | Common Stock | 23,703 | 23,703 | D |
| Right to Buy Restricted Stock Unit (RSU)F2,F1 | — | Oct 20, 2016 | M | 23,703 | A | Oct 20, 2017 | — | Common Stock | 23,703 | 23,703 | D |
Explanation of responses
- F1Restricted Stock Units will vest on the 1st anniversary of the grant date and will be automatically settled in shares of common stock.
- F2The restricted stock units convert into common stock of Landec Corporation on a 1 for 1 basis.
- F3Restricted Stock Units will vest on the 2nd anniversary of the grant date and will be automatically settled in shares of common stock.